Showing results (231-240 of 378) with videos related to
Sort By:
Pageof 38
Critical Reviews in Oncology/Hematology|April 25, 2012
Turning promise into progress for antiangiogenic agents in epithelial ovarian cancerArne R M van der Bilt, Elisabeth G E de Vries, Steven de Jong, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2006
The clinical trail of TRAILE W Duiker, C H Mom, S de Jong, et al.Journal of Medical Genetics|August 3, 2005
Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive studyM Zoodsma, I M Nolte, M Schipper, et al.Gynecologic Oncology|November 9, 2010
Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical resultsL M A Crane, G Themelis, H J G Arts, et al.Human Genetics|January 7, 2005
Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical diseaseMargreet Zoodsma, Ilja M Nolte, Martin Schipper, et al.Molecular Imaging|April 28, 2011
Intraoperative imaging in ovarian cancer: fact or fiction?Lucia M A Crane, Marleen van Oosten, Rick G Pleijhuis, et al.European Journal of Cancer & Clinical Oncology|August 1, 1989
Temperature distribution and pH changes during hyperthermic regional isolation perfusionJ van der Zee, M P Broekmeyer-Reurink, A P van den Berg, et al.Human Mutation|December 25, 2007
Progranulin locus deletion in frontotemporal dementiaI Gijselinck, J van der Zee, S Engelborghs, et al.Cancer Letters|July 19, 2019
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinomaJoseph J Caumanns, Anne van Wijngaarden, Arjan Kol, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical diseaseM Zoodsma, I M Nolte, M Schipper, et al.Pageof 38